VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

10047	Companies
204823	Keywords
135077	Articles
108596	Press releases

Home
Companies
VALNEVA

BRIEF

published on 06/04/2025 at 07:05, 9 months 13 days ago

Valneva: Documents for the General Meeting and Change of Management

Direction General Assembly Valneva Preparatory Documents Vaccines
PRESS RELEASE

published on 06/04/2025 at 07:00, 9 months 13 days ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva SE announces availability of documentation for its Combined Shareholder Meeting on June 25, 2025, along with corporate update and executive departure. Details on accessing meeting documents and farewell to Mr. Grimaud

Corporate Update Valneva SE Shareholder Meeting Vaccine Company Franck Grimaud
BRIEF

published on 05/21/2025 at 13:36, 9 months 27 days ago

Valneva SE: Research Update Reaffirms Buy Rating, Raises Target Price

Target Price Financial Growth Valneva Market Forecast Lyme Vaccine
PRESS RELEASE

published on 05/21/2025 at 13:31, 9 months 27 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research increases price target for Valneva SE to €8.10 following strong Q1/25 results and positive outlook on Lyme disease vaccine candidate, VLA15

First Berlin Equity Research Price Target Valneva SE Lyme Disease Vaccine Q1/25 Results
BRIEF

published on 04/26/2025 at 19:15, 10 months 21 days ago

Partial suspension of the use of Valneva's IXCHIQ® vaccine

Security Valneva France Vaccine Chikungunya
PRESS RELEASE

published on 04/26/2025 at 19:10, 10 months 21 days ago

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Valneva SE provides an update on the recommendation for the use of its Chikungunya vaccine by French authorities, focusing on adverse events in elderly people. The company is collaborating with regulators on next steps

Valneva SE Chikungunya Vaccine French Authorities Adverse Events Elderly
BRIEF

published on 04/18/2025 at 10:05, 10 months 29 days ago

Valneva Updates on Chikungunya Vaccine Recommendation in the U.S.

Valneva Chikungunya Vaccine IXCHIQ® ACIP Recommendation U.S. Travelers
PRESS RELEASE

published on 04/18/2025 at 10:00, 10 months 29 days ago

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Valneva provides update on ACIP recommendation for its chikungunya vaccine IXCHIQ® among U.S. travelers, highlighting new precaution for persons aged 65 years and ongoing safety monitoring

Valneva CDC Chikungunya Vaccine IXCHIQ® ACIP Recommendation
BRIEF

published on 04/09/2025 at 07:05, 11 months 8 days ago

First child vaccinated in Phase 2 study of S4V2 shigellosis vaccine

Valneva Phase 2 Shigellosis S4V2 Vaccine Pediatric Trial
PRESS RELEASE

published on 04/09/2025 at 07:00, 11 months 8 days ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease

Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech

Accesswire

Published on 03/17/2026 at 23:10, 26 minutes ago

Redwood AI CEO Louis Dron Featured on Conversations That Matter to Discuss AI Chemistry Platform and Broader Applications
Published on 03/17/2026 at 22:30, 1 hour 6 minutes ago

Galway Metals Appoints Red Cloud Financial Services to Provide Financial Advisory and Promotional Services
Published on 03/17/2026 at 21:30, 2 hours 6 minutes ago

Rainy Mountain Announces Appointment of Colton Griffith to Board of Directors
Published on 03/17/2026 at 21:10, 2 hours 26 minutes ago

BTU Announces Financing
Published on 03/17/2026 at 13:30, 10 hours 6 minutes ago

Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026

View all ACCESSWIRE

EQS Group

Published on 03/17/2026 at 21:21, 2 hours 14 minutes ago

KION GROUP AG successfully places a bond of € 500 million
Published on 03/17/2026 at 20:55, 2 hours 40 minutes ago

EQS-Adhoc: thyssenkrupp nucera lowers its sales and EBIT outlook for the Group and the gH2 segment for FY 2025/26 due to higher project costs
Published on 03/17/2026 at 18:07, 5 hours 28 minutes ago

POS-Transaction in Own Shares
Published on 03/17/2026 at 17:58, 5 hours 38 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 17:45, 5 hours 50 minutes ago

FIGEAC AÉRO: THREE NEW WINS IN MEXICO

Les Echos

Published on 03/17/2026 at 07:00, 16 hours 36 minutes ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 5 hours ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 5 hours ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 5 hours ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 1 day 5 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE